Researchers say the rheumatoid arthritis drug Remicade can ease the suffering of patients with moderate to severe psoriasis for up to one year. The drug, marketed by Johnson & Johnson and Schering-Plough, also produced substantial improvement in nail disease, one of the most troublesome features of psoriasis, the study showed.

Full Story:

Related Summaries